Reproductive BioMedicine Online
Volume 19, Issue 4 , Pages 456-471 , October 2009

Aromatase inhibitors for female infertility: a systematic review of the literature

  • Nikolaos P. Polyzos

      Affiliations

    • PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology and Public Health, Athens 10438, Greece
    • Corresponding Author InformationCorrespondence:
    • ,
  • Spyridon Tzioras

      Affiliations

    • Royal Free Hospital, Department of Obstetrics and Gynecology, London NW3 2QG, UK
    • ,
  • Ahmed M. Badawy

      Affiliations

    • Mansoura University, Department of Obstetrics and Gynecology, Mansoura 35111, Egypt
    • ,
  • Antonis Valachis

      Affiliations

    • PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology and Public Health, Athens 10438, Greece
    • ,
  • Charalabos Dritsas

      Affiliations

    • PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology and Public Health, Athens 10438, Greece
    • ,
  • Davide Mauri

      Affiliations

    • PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology and Public Health, Athens 10438, Greece

Received 20 November 2008 ,Revised 7 January 2009 ,Accepted 10 June 2009.

References 

  1. Al-Fadhli R, Sylvestre C, Buckett W, et al. Randomized trial of superovulation with two different doses of letrozole. Fertility and Sterility. 2006;85:161–164
  2. Al-Fozan H, Al-Khadouri M, Tan SL, et al. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertility and Sterility. 2004;82:1561–1563
  3. Al-Omari WR, Sulaiman WR, Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics. 2004;85:289–291
  4. Amer S http://clinicaltrials.gov/ct2/show/NCT0047850.
  5. Atay V, Cam C, Muhcu M, et al. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research. 2006;34:73–76
  6. Badawy A, Mosbah A, Tharwat A, et al. Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertility and Sterility. 2009;92:236–239
  7. Badawy A, Shokeir T, Allam AF, et al. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstetricia et Gynecologica Scandinavica. 2009;88:187–191
  8. Badawy A, Elnashar A, Totongy M. Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial. Fertility and Sterility. 2008;
  9. Badawy A, Mosbah A, Shady M. Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial. Fertility and Sterility. 2008;89:1209–1212
  10. Badawy A, Aal IA, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertility and Sterility. 2007;
  11. Badawy A, Aal IA, Abulatta M. Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial. Fertility and Sterility. 2007;
  12. Badawy A, Metwally M, Fawzy M. Randomized controlled trial of three doses of letrozole for ovulation induction in patients with unexplained infertility. Reproductive BioMedicine Online. 2007;14:559–562
  13. Barroso G, Menocal G, Felix H, et al. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial. Fertility and Sterility. 2006;86:1428–1431
  14. Baruah J, Roy KK, Rahman SM, et al. Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler. Archives in Gynecology and Obstetrics. 2009;279:311–314
  15. Bayar U, Basaran M, Kiran S, et al. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility and Sterility. 2006;86:1447–1451
  16. Bayar U, Tanriverdi HA, Barut A, et al. Letrozole versus clomiphene citrate in patients with ovulatory infertility. Fertility and Sterility. 2006;85:1045–1048
  17. Baysoy A, Serdaroglu H, Jamal H, et al. Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination. Reproductive BioMedicine Online. 2006;13:208–212
  18. Bedaiwy MA, Forman R, Mousa NA, et al. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. Human Reproduction. 2006;21:2838–2844
  19. Begum MR, Ferdous J, Begum A, et al. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. Fertility and Sterility. 2008;
  20. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotrophins. Fertility and Sterility. 2005;84:O-231, Abstract 1033
  21. Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. Journal of Clinical Endocrinology and Metabolism. 2006;91:760–771
  22. Dahan MH, Quintero RB, Urban R. A comparison of letrozole to gonadotrophins for ovulation induction in subjects with advanced maternal age: a retrospective pilot study. Fertility and Sterility. 2008;90:1226–1228
  23. Dankert T, Kremer JA, Cohlen BJ, et al. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Human Reproduction. 2007;22:792–797
  24. Eisenberg E, Santoro N, Legro R et al. http://clinicaltrials.gov/ct2/show/NCT00719186.
  25. Esmailzadeh S, Faramarzi M. Endometrial thickness and pregnancy outcome after intrauterine insemination. Fertility and Sterility. 2007;88:432–437
  26. Fatemi HM, Kolibianakis E, Tournaye H, et al. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reproductive BioMedicine Online. 2003;7:543–546
  27. Ganesh A, Goswami SK, Chattopadhyay R, et al. Comparison of letrozole with continuous gonadotrophins and clomiphene-gonadotrophin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial. Journal of Assisted Reproduction and Genetics. 2009;26:19–24
  28. Garcia-Velasco JA, Moreno L, Pacheco A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertility and Sterility. 2005;84:82–87
  29. Goswami SK, Das T, Chattopadhyay R, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Human Reproduction. 2004;19:2031–2035
  30. Gregoriou O, Vlahos NF, Konidaris S, et al. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined to intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination. Fertility and Sterility. 2008;90:678–683
  31. Griesinger G, von Otte S, Schultze-Mosgau A, et al. Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison. Fertility and Sterility. 2009;90:678–683
  32. Healey S, Tan SL, Tulandi T, et al. Effects of letrozole on superovulation with gonadotrophins in women undergoing intrauterine insemination. Fertility and Sterility. 2003;80:1325–1329
  33. Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database of Systematic Reviews. 2000;3:CD000057
  34. Imani B, Eijkemans MJ, te Velde ER, et al. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotrophic oligoamenorrheic infertility. Fertility and Sterility. 2002;77:91–97
  35. Jee BC, Ku SY, Suh CS, et al. Use of letrozole versus clomiphene citrate combined with gonadotrophins in intrauterine insemination cycles: a pilot study. Fertility and Sterility. 2006;85:1774–1777
  36. Kolibianakis EM, Zikopoulos KA, Fatemi HM, et al. Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reproductive BioMedicine Online. 2004;8:115–118
  37. Mauri D, Pavlidis N, Polyzos NP, et al. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. Journal of National Cancer Institute. 2006;98:1285–1291
  38. Messinis IE. Ovulation induction: a mini review. Human Reproduction. 2005;20:2688–2697
  39. Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertility and Sterility. 2005;3:229–231
  40. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Human Reproduction. 2003;18:1588–1597
  41. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertility and Sterility. 2002;77:776–780
  42. Noriega-Portella L, Noriega-Hoces L, Delgado A, et al. Effect of letrozole at 2.5mg or 5.0mg/day on ovarian stimulation with gonadotrophins in women undergoing intrauterine insemination. Fertility and Sterility. 2008;90:1818–1825
  43. Polyzos NP, Mauri D, Tzioras S. Letrozole in ovulation induction: time to make decisions. Human Reproduction Update. 2009;15:263–264
  44. Polyzos NP, Tsappi M, Mauri D, et al. Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?. Fertility and Sterility. 2008;89:278–280
  45. Polyzos NP, Tzioras S, Mauri D, et al. Treatment of unexplained infertility with aromatase inhibitors or clomiphene citrate: a systematic review and meta-analysis. Obstetrical and Gynecological Survey. 2008;63:472–479
  46. Prapas G, Pistofidis M, Tika M, et al. Experience with the use of an aromatase inhibitor letrozole in patients with a history of poor ovarian response in previous assisted reproduction cycles (abstract). Human Reproduction. 2002;7:S75
  47. Quintero RB, Urban R, Lathi RB, et al. A comparison of letrozole to gonadotrophins for ovulation induction, in subjects who failed to conceive with clomiphene citrate. Fertility and Sterility. 2007;88:879–885
  48. Sammour A, Biljan MM, Tan SL, et al. Prospective randomized trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI). Fertility and Sterility. 2001;76:S110
  49. Schoolcraft W, Surrey E, Minjarez D, et al. Antagonist/letrozole protocol for patients failing microdose agonist flare stimulation. Fertility and Sterility. 2002;78:S234
  50. Sh Tehrani Nejad E, Abediasl Z, et al. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotrophins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial. Journal of Assisted Reproduction and Genetics. 2008;25:187–190
  51. Sipe CS, Davis WA, Maifeld M, et al. A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotrophins. Fertility and Sterility. 2006;86:1676–1681
  52. Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Human Reproduction. 2006;21:1432–1435
  53. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008 Consensus on infertility treatment related to polycystic ovary syndrome. Fertility and Sterility 89, 505–522.
  54. Tiboni GM, Marotta F, Rossi C, et al. Effects of the aromatase inhibitor letrozole on in utero development in rats. Human Reproduction. 2008;23:1719–1723
  55. Tredway DR http://clinicaltrials.gov/ct2/show/NCT00213148.
  56. Tulandi T, Martin J, Al-Fadhli R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertility and Sterility. 2006;85:1761–1765
  57. Verpoest WM, Kolibianakis E, Papanikolaou E, et al. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reproductive BioMedicine Online. 2006;13:166–172
  58. Wu HH, Wang NM, Cheng ML, et al. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility. Gynecologic Endocrinology. 2007;23:76–78
  59. Zayed F, Abu-Heija A. The management of unexplained infertility. Obstetrical and Gynecological Survey. 1999;54:121–130

 Dr Nikolaos P Polyzos graduated from University of Ioannina in Greece. Since 2004 he has been the Head Researcher at the Section of Obstetrics and Gynaecology, Panhellenic Association for Continual Medical Research (PACMeR). He is the author of several publications on aromatase inhibitors in ovulation induction and treatment of advanced breast cancer published in high impact journals.Dr Nikolaos Polyzos

PII: S1472-6483(09)00022-4

doi: 10.1016/j.rbmo.2009.06.008

Reproductive BioMedicine Online
Volume 19, Issue 4 , Pages 456-471 , October 2009

Article Tools